{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:10:41Z","timestamp":1779210641076,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["comit\u00e9 Allier et Puy de D\u00f4me"],"award-info":[{"award-number":["comit\u00e9 Allier et Puy de D\u00f4me"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-026-01423-x","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T14:32:25Z","timestamp":1775313145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preclinical in vivo dosimetry of healthy tissues in radiopharmaceutical therapy: implementation of a physiologically realistic mouse eye model in GATE"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-4055","authenticated-orcid":false,"given":"Elodie","family":"Jouberton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Sas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommy","family":"Billoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Auzeloux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Mazuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Chezal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Miot-Noirault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Ranchon-Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florent","family":"Cachin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"1423_CR1","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/S1470-2045(21)00572-6","volume":"22","author":"JR Strosberg","year":"2021","unstructured":"Strosberg JR, Caplin ME, Kunz PL, et al. 177Lu-Dotatate plus long-acting octreotide versus high\u2013dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial. Lancet Oncol. 2021;22:1752\u201363.","journal-title":"Lancet Oncol"},{"key":"1423_CR2","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","volume":"385","author":"O Sartor","year":"2021","unstructured":"Sartor O, de Bono J, Chi KN, et al. Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer. N Engl J Med. 2021;385:1091\u2013103.","journal-title":"N Engl J Med"},{"key":"1423_CR3","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S1470-2045(22)00605-2","volume":"23","author":"JP Buteau","year":"2022","unstructured":"Buteau JP, Martin AJ, Emmett L, et al. PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial. Lancet Oncol. 2022;23:1389\u201397.","journal-title":"Lancet Oncol"},{"key":"1423_CR4","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1016\/S0140-6736(24)00701-3","volume":"403","author":"S Singh","year":"2024","unstructured":"Singh S, Halperin D, Myrehaug S, et al. [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high\u2013dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2\u20133, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study. Lancet. 2024;403:2807\u201317.","journal-title":"Lancet"},{"key":"1423_CR5","unstructured":"Directive\u2009\u2013\u20092013\/59 - EN - EUR-Lex. https:\/\/eur-lex.europa.eu\/eli\/dir\/2013\/59\/oj\/eng. Accessed 21 Nov 2024."},{"key":"1423_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/cells15010073","volume":"15","author":"M Bruzgo-Grzybko","year":"2025","unstructured":"Bruzgo-Grzybko M, Kalita IS, Olichwier AJ, Bielicka N, Chabielska E, Gromotowicz-Poplawska A. Preclinical PET and SPECT Imaging in Small Animals: Technologies, Challenges and Translational Impact. Cells. 2025;15:73.","journal-title":"Cells"},{"key":"1423_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40658-025-00778-9","volume":"12","author":"AP Robinson","year":"2025","unstructured":"Robinson AP, Ferreira KM, Heetun W, Bardi\u00e8s M, Denis-Bacelar AM, Fenwick AJ, Lassmann M, Tipping J, Tran-Gia J. Establishing measurement traceability for quantitative SPECT imaging. EJNMMI Phys. 2025;12:58.","journal-title":"EJNMMI Phys"},{"key":"1423_CR8","doi-asserted-by":"publisher","first-page":"064301","DOI":"10.1118\/1.4871617","volume":"41","author":"D Sarrut","year":"2014","unstructured":"Sarrut D, Bardi\u00e8s M, Boussion N, et al. A review of the use and potential of the GATE Monte Carlo simulation code for radiation therapy and dosimetry applications. Med Phys. 2014;41:064301.","journal-title":"Med Phys"},{"key":"1423_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/ijc.24413","volume":"125","author":"M Bonnet-Duquennoy","year":"2009","unstructured":"Bonnet-Duquennoy M, Papon J, Mishellany F, et al. Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agent. Int J Cancer. 2009;125:708\u201316.","journal-title":"Int J Cancer"},{"key":"1423_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1684\/ejd.2014.2481","volume":"25","author":"C Viallard","year":"2015","unstructured":"Viallard C, Perrot Y, Boudhraa Z, et al. [123I]ICF01012 melanoma imaging and [131I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models. Eur J Dermatol. 2015;25:29\u201335.","journal-title":"Eur J Dermatol"},{"key":"1423_CR11","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3390\/cancers13061421","volume":"13","author":"H Akil","year":"2021","unstructured":"Akil H, Quintana M, Raymond JH, et al. Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma. Cancers (Basel). 2021;13:1421.","journal-title":"Cancers (Basel)"},{"key":"1423_CR12","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.tranon.2019.07.015","volume":"12","author":"H Akil","year":"2019","unstructured":"Akil H, Rouanet J, Viallard C, Besse S, Auzeloux P, Chezal J-M, Miot-Noirault E, Quintana M, Degoul F. Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms. Translational Oncol. 2019;12:1442\u201352.","journal-title":"Translational Oncol"},{"key":"1423_CR13","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00262-020-02606-8","volume":"69","author":"J Rouanet","year":"2020","unstructured":"Rouanet J, Benboubker V, Akil H, et al. Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy. Cancer Immunol Immunother. 2020;69:2075\u201388.","journal-title":"Cancer Immunol Immunother"},{"key":"1423_CR14","doi-asserted-by":"publisher","first-page":"12927","DOI":"10.18632\/oncotarget.7340","volume":"7","author":"C Viallard","year":"2016","unstructured":"Viallard C, Chezal J-M, Mishellany F, et al. Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapy. Oncotarget. 2016;7:12927\u201336.","journal-title":"Oncotarget"},{"key":"1423_CR15","doi-asserted-by":"publisher","first-page":"107829","DOI":"10.1016\/j.pharmthera.2021.107829","volume":"224","author":"J Rouanet","year":"2021","unstructured":"Rouanet J, Quintana M, Auzeloux P, Cachin F, Degoul F. Benzamide derivative radiotracers targeting melanin for melanoma imaging and therapy: Preclinical\/clinical development and combination with other treatments. Pharmacol Ther. 2021;224:107829.","journal-title":"Pharmacol Ther"},{"key":"1423_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s12885-022-09495-3","volume":"22","author":"E Thivat","year":"2022","unstructured":"Thivat E, Rouanet J, Auzeloux P, et al. Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol. BMC Cancer. 2022;22:417.","journal-title":"BMC Cancer"},{"key":"1423_CR17","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1751-1097.2008.00316.x","volume":"84","author":"D-N Hu","year":"2008","unstructured":"Hu D-N, Simon JD, Sarna T. Role of Ocular Melanin in Ophthalmic Physiology and Pathology. Photochem Photobiol. 2008;84:639\u201344.","journal-title":"Photochem Photobiol"},{"key":"1423_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1152\/physrev.00021.2004","volume":"85","author":"O Strauss","year":"2005","unstructured":"Strauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005;85:845\u201381.","journal-title":"Physiol Rev"},{"key":"1423_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2967\/jnumed.108.056036","volume":"50","author":"WE Bolch","year":"2009","unstructured":"Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD Pamphlet 21: A Generalized Schema for Radiopharmaceutical Dosimetry\u2014Standardization of Nomenclature. J Nucl Med. 2009;50:477\u201384.","journal-title":"J Nucl Med"},{"key":"1423_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0168-583X(95)00349-5","volume":"100","author":"J Bar\u00f3","year":"1995","unstructured":"Bar\u00f3 J, Sempau J, Fern\u00e1ndez-Varea JM, Salvat F. PENELOPE: An algorithm for Monte Carlo simulation of the penetration and energy loss of electrons and positrons in matter. Nucl Instrum Methods Phys Res Sect B. 1995;100:31\u201346.","journal-title":"Nucl Instrum Methods Phys Res Sect B"},{"key":"1423_CR21","doi-asserted-by":"publisher","first-page":"108879","DOI":"10.1016\/j.radphyschem.2020.108879","volume":"173","author":"CCO Silva","year":"2020","unstructured":"Silva CCO, Berdeguez MBT, Barboza T, Souza SAL, Braz D, Silva AX, Sa LV. Preclinical radiation internal dosimetry in the development of new radiopharmaceuticals using GATE Monte Carlo simulation. Radiat Phys Chem. 2020;173:108879.","journal-title":"Radiat Phys Chem"},{"key":"1423_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1118\/1.4937598","volume":"43","author":"T Xie","year":"2016","unstructured":"Xie T, Zaidi H. Development of computational small animal models and their applications in preclinical imaging and therapy research. Med Phys. 2016;43:111\u201331.","journal-title":"Med Phys"},{"key":"1423_CR23","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1088\/0031-9155\/52\/4\/010","volume":"52","author":"A Bitar","year":"2007","unstructured":"Bitar A, Lisbona A, Thedrez P, Sai Maurel C, Le Forestier D, Barbet J, Bardies M. A voxel-based mouse for internal dose calculations using Monte Carlo simulations (MCNP). Phys Med Biol. 2007;52:1013\u201325.","journal-title":"Phys Med Biol"},{"key":"1423_CR24","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1088\/0031-9155\/61\/6\/2333","volume":"61","author":"T Kostou","year":"2016","unstructured":"Kostou T, Papadimitroulas P, Loudos G, Kagadis GC. A preclinical simulated dataset of S-values and investigation of the impact of rescaled organ masses using the MOBY phantom. Phys Med Biol. 2016;61:2333.","journal-title":"Phys Med Biol"},{"key":"1423_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2967\/jnumed.109.070532","volume":"51","author":"MA Keenan","year":"2010","unstructured":"Keenan MA, Stabin MG, Segars WP, Fernald MJ. RADAR Realistic Animal Model Series for Dose Assessment. J Nucl Med. 2010;51:471\u20136.","journal-title":"J Nucl Med"},{"key":"1423_CR26","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1021\/jm701424g","volume":"51","author":"J-M Chezal","year":"2008","unstructured":"Chezal J-M, Papon J, Labarre P, et al. Evaluation of Radiolabeled (Hetero)Aromatic Analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for Imaging and Targeted Radionuclide Therapy of Melanoma. J Med Chem. 2008;51:3133\u201344.","journal-title":"J Med Chem"},{"key":"1423_CR27","unstructured":"Madelmont J-C, Chezal J-M, Chavignon O, Teulade J-C, Moins N. (2011) Analogues d\u2019halobenzamides marqu\u00e9s en tant que radiopharmaceutiques."},{"key":"1423_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13550-025-01319-2","volume":"15","author":"E Jouberton","year":"2025","unstructured":"Jouberton E, Besse S, Billoux T, et al. Tumor sink effect on melanin-ligand [131I]ICF01012 in melanoma and its implications for targeted radionuclide therapy. EJNMMI Res. 2025;15:125.","journal-title":"EJNMMI Res"},{"key":"1423_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.bbagen.2005.05.013","volume":"1724","author":"J-L Guerquin-Kern","year":"2005","unstructured":"Guerquin-Kern J-L, Wu T-D, Quintana C, Croisy A. Progress in analytical imaging of the cell by dynamic secondary ion mass spectrometry (SIMS microscopy). Biochimica et Biophysica Acta (BBA). - Gen Subj. 2005;1724:228\u201338.","journal-title":"- Gen Subj"},{"key":"1423_CR30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135.","journal-title":"Nat Methods"},{"key":"1423_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/jbiol42","volume":"5","author":"C Lechene","year":"2006","unstructured":"Lechene C, Hillion F, McMahon G, et al. High-resolution quantitative imaging of mammalian and bacterial cells using stable isotope mass spectrometry. J Biol. 2006;5:20.","journal-title":"J Biol"},{"key":"1423_CR32","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1088\/0031-9155\/56\/4\/001","volume":"56","author":"S Jan","year":"2011","unstructured":"Jan S, Benoit D, Becheva E, et al. GATE V6: a major enhancement of the GATE simulation platform enabling modelling of CT and radiotherapy. Phys Med Biol. 2011;56:881\u2013901.","journal-title":"Phys Med Biol"},{"key":"1423_CR33","doi-asserted-by":"publisher","first-page":"12931","DOI":"10.1073\/pnas.1921224117","volume":"117","author":"B Chen","year":"2020","unstructured":"Chen B, Aredo B, Ding Y, et al. Forward genetic analysis using OCT screening identifies Sfxn3 mutations leading to progressive outer retinal degeneration in mice. Proc Natl Acad Sci USA. 2020;117:12931\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1423_CR34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40658-022-00512-9","volume":"9","author":"L Carnegie-Peake","year":"2022","unstructured":"Carnegie-Peake L, Taprogge J, Murray I, Flux GD, Gear J. Quantification and dosimetry of small volumes including associated uncertainty estimation. EJNMMI Phys. 2022;9:86.","journal-title":"EJNMMI Phys"},{"key":"1423_CR35","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1118\/1.1781553","volume":"31","author":"T Funk","year":"2004","unstructured":"Funk T, Sun M, Hasegawa BH. Radiation dose estimate in small animal SPECT and PET. Med Phys. 2004;31:2680\u20136.","journal-title":"Med Phys"},{"key":"1423_CR36","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1002\/mp.13165","volume":"45","author":"E Jouberton","year":"2018","unstructured":"Jouberton E, Perrot Y, Dirat B, et al. Radiation dosimetry of [131 I]ICF01012 in rabbits: Application to targeted radionuclide therapy for human melanoma treatment. Med Phys. 2018;45:5251\u201362.","journal-title":"Med Phys"},{"key":"1423_CR37","doi-asserted-by":"publisher","first-page":"7656","DOI":"10.1038\/s41598-020-64601-4","volume":"10","author":"M Matsuzaki","year":"2020","unstructured":"Matsuzaki M, Mandai M, Yamanari M, et al. Polarization-sensitive optical coherence tomography for estimating relative melanin content of autologous induced stem-cell derived retinal pigment epithelium. Sci Rep. 2020;10:7656.","journal-title":"Sci Rep"},{"key":"1423_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1089\/jop.1992.8.35","volume":"8","author":"IA Menon","year":"1992","unstructured":"Menon IA, Wakeham DC, Persad SD, Avaria M, Trope GE, Basu PK. Quantitative determination of the melanin contents in ocular tissues from human blue and brown eyes. J Ocul Pharmacol. 1992;8:35\u201342.","journal-title":"J Ocul Pharmacol"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-026-01423-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01423-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01423-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:50:22Z","timestamp":1779209422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-026-01423-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1423"],"URL":"https:\/\/doi.org\/10.1186\/s13550-026-01423-x","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with ethical principles and approved protocols outlined by local Ethic committee of Clermont-Ferrand and French Ministry of Education and Research (Approval N\u00b0 37046). No human studies were done. Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}